4.8 Article

Baricitinib Attenuates Autoimmune Phenotype and Podocyte Injury in a Murine Model of Systemic Lupus Erythematosus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Kinase inhibition in autoimmunity and inflammation

Ali A. Zarrin et al.

Summary: There are still unmet medical needs in the treatment of autoimmune and inflammatory diseases, despite recent advances in the field. Inhibitors targeting the activity of kinases that regulate production of inflammatory mediators have shown promising progress in drug development.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Medicine, General & Internal

Lupus nephritis

Hans-Joachim Anders et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Immunology

Crosstalk between the Producers and Immune Targets of IL-9

Van Anh Thi et al.

IMMUNE NETWORK (2020)

Article Medicine, Research & Experimental

Double negative T cells, a potential biomarker for systemic lupus erythematosus

Jessy J. Alexander et al.

PRECISION CLINICAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus

Kongyang Ma et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Pharmacology & Pharmacy

The Jakinibs in systemic lupus erythematosus: progress and prospects

Chi Chiu Mok

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Review Immunology

The role of cytokines in T-cell memory in health and disease

Miro E. Raeber et al.

IMMUNOLOGICAL REVIEWS (2018)

Article Immunology

Janus Kinase inhibitor Baricitinib Modulates human innate and adaptive immune system

Satoshi Kubo et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Rheumatology

Mouse models of lupus: what they tell us and what they don't

Mara Lennard Richard et al.

LUPUS SCIENCE & MEDICINE (2018)

Article Physiology

Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis

Rachael D. Wright et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)

Article Rheumatology

Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction

Yasuko Furumoto et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Article Urology & Nephrology

Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice

Hongyu Zhang et al.

KIDNEY INTERNATIONAL (2017)

Review Biotechnology & Applied Microbiology

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Daniella M. Schwartz et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

Article Medicine, General & Internal

Systemic lupus erythematosus

Arvind Kaul et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Letter Rheumatology

Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Sheau-Pey Wang et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Review Immunology

Type I Interferon in the Pathogenesis of Lupus

Mary K. Crow

JOURNAL OF IMMUNOLOGY (2014)

Review Immunology

B-cell-targeted therapies in systemic lupus erythematosus

Vera Sau-Fong Chan et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2013)